
Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities
Author(s) -
Kouichi Miura,
Hiroshi Maeda,
Naoki Morimoto,
Shunji Watanabe,
Mamiko Tsukui,
Yuri Takaoka,
Hiroaki Nomoto,
Rie Goka,
Kazuhiko Kotani,
Hironori Yamamoto
Publication year - 2022
Publication title -
world journal of gastrointestinal pathophysiology
Language(s) - English
Resource type - Journals
ISSN - 2150-5330
DOI - 10.4291/wjgp.v13.i3.96
Subject(s) - medicine , transient elastography , nonalcoholic fatty liver disease , fatty liver , gastroenterology , fibrosis , metabolic syndrome , disease , liver fibrosis , obesity
Vibration-controlled transient elastography (VCTE) is proposed as a second step of examination to assess liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) after triaging by the fibrosis-4 (FIB-4) index. Recently, VCTE-based scoring systems, including FibroScan-AST (FAST), Agile 3+, and Agile 4, emerged to determine the status of NAFLD. However, the significance of these scoring systems remains unknown in narrowing the high-risk group of NAFLD patients with comorbidities, including hepatocellular carcinoma (HCC) and esophagogastric varices (EGV).